World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 86 13961 13146 460 449 620 32746

Jeff Szer publications per year

The chart shows the history of publications by Jeff Szer between 1980 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jeff Szer published across 46 years, from 1980 to 2025, averaging 14.7 papers a year. Output peaked at 37 publications in 2018. 41 of the 675 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1980 to 2025. Vertical axis: number of publications, 0 to 37. Peak 37 publications in 2018. 1980: 1 publication 1981: 0 publications 1982: 0 publications 1983: 2 publications 1984: 1 publication 1985: 5 publications 1986: 0 publications 1987: 2 publications 1988: 4 publications 1989: 1 publication 1990: 1 publication 1991: 8 publications 1992: 12 publications 1993: 7 publications 1994: 8 publications 1995: 9 publications 1996: 10 publications 1997: 13 publications 1998: 6 publications 1999: 10 publications 2000: 7 publications 2001: 14 publications 2002: 9 publications 2003: 9 publications 2004: 23 publications 2005: 12 publications 2006: 28 publications 2007: 18 publications 2008: 19 publications 2009: 12 publications 2010: 18 publications 2011: 19 publications 2012: 24 publications 2013: 35 publications 2014: 28 publications 2015: 27 publications 2016: 32 publications 2017: 29 publications 2018: 37 publications 2019: 22 publications 2020: 37 publications 2021: 24 publications 2022: 21 publications 2023: 30 publications 2024: 21 publications 2025: 20 publications
1980 2025

675 publications in total across all disciplines

View publications per year as a table
Jeff Szer: publications per year, 1980 to 2025
Year Publications
1980 1
1981 0
1982 0
1983 2
1984 1
1985 5
1986 0
1987 2
1988 4
1989 1
1990 1
1991 8
1992 12
1993 7
1994 8
1995 9
1996 10
1997 13
1998 6
1999 10
2000 7
2001 14
2002 9
2003 9
2004 23
2005 12
2006 28
2007 18
2008 19
2009 12
2010 18
2011 19
2012 24
2013 35
2014 28
2015 27
2016 32
2017 29
2018 37
2019 22
2020 37
2021 24
2022 21
2023 30
2024 21
2025 20
Total 675
Download as CSV

Jeff Szer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jeff Szer sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 601–620 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 620 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396 620
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Jeff Szer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jeff Szer sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 86–87 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960 86
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Jeff Szer is a researcher affiliated with the Peter MacCallum Cancer Centre in Australia. Their scholarly work is concentrated within the field of Medicine, with particular emphasis on Hematology, Immunology, and Genetics. The subfields that feature prominently in their research include Physiology and Public Health, Environmental and Occupational Health.

The main topics addressed in their publications reflect a focus on blood and immune system-related medical issues. These topics include:

  • Complement system in diseases
  • Hematopoietic Stem Cell Transplantation
  • Blood groups and transfusion
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Acute Myeloid Leukemia Research
  • Lysosomal Storage Disorders Research
  • Renal Diseases and Glomerulopathies

Jeff Szer has contributed to a variety of scientific articles across multiple respected journals. Frequent publication venues for their work include:

  • Internal Medicine Journal
  • Blood
  • Haematologica
  • The Lancet Haematology
  • Bone Marrow Transplantation

Their recent papers cover notable studies in the areas of hematology and treatment of blood-related diseases, including:

  • "Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease", 2020, New England Journal of Medicine
  • "Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria", 2021, New England Journal of Medicine
  • "One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors", 2021, Haematologica
  • "Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance", 2020, The Medical Journal of Australia
  • "Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria", 2020, Haematologica

The researcher frequently collaborates with other scientists, with the most common coauthors being:

  • Régis Peffault de Latour
  • Mahmoud Aljurf
  • Morag Griffin
  • Dietger Niederwieser
  • Mickey Koh

Best Publications

  • The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

    Peter Hillmen;Neal S. Young;Jörg Schubert;Robert A. Brodsky

  • Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

    W.P. Sheridan;R.M. Fox;C.G. Begley;D. Maher

  • Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis

    Susan Branford;Zbigniew Rudzki;Sonya Walsh;Ian Parkinson

  • Hematopoietic stem cell transplantation: a global perspective

    Alois Gratwohl;Helen Baldomero;Mahmoud Aljurf;Marcelo C. Pasquini

  • Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

    Robert Zeiser;Nikolas von Bubnoff;Jason Butler;Mohamad Mohty

  • Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

    Peter Hillmen;Petra Muus;Ulrich Dührsen;Antonio M. Risitano

  • Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

    Navneet S. Majhail;Navneet S. Majhail;J. Douglas Rizzo;Stephanie J. Lee;Mahmoud Aljurf

  • A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.

    JF Bishop;JP Matthews;Ga Young;J Szer

  • A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers

    Simon J Stanworth;Lise J Estcourt;Lise J Estcourt;Gillian Powter;Brennan C Kahan

  • One million haemopoietic stem-cell transplants: a retrospective observational study

    Alois Gratwohl;Marcelo C Pasquini;Mahmoud Aljurf;Yoshiko Atsuta

  • Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

    Peter Hillmen;Petra Muus;Alexander Roth;Modupe O. Elebute

  • A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

    Gerhard Heil;Dieter Hoelzer;Miguel A. Sanz;Klaus Lechner

  • Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

    Dietger Niederwieser;Helen Baldomero;Jeff Szer;Michael Gratwohl

  • All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

    Harry J. Iland;Harry J. Iland;Ken Bradstock;Ken Bradstock;Shane G. Supple;Alberto Catalano

  • Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial.

    Mats Brune;Sylvie Castaigne;John Catalano;Kurt Gehlsen

  • Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

    Robert J. Soiffer;Haesook T. Kim;Joseph McGuirk;Mitchell E. Horwitz

  • Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study.

    Austin G. Kulasekararaj;Anita Hill;Scott T. Rottinghaus;Saskia Langemeijer

  • Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia

    Brian J P Huntly;Alistair G Reid;Anthony J Bench;L J Campbell

  • Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.

    Norbert Schmitz;Meral Beksac;Dirk Hasenclever;Andrea Bacigalupo

  • Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.

    A Grigg;C G Begley;C A Juttner;J Szer

Frequent Co-Authors

David Ritchie
David Ritchie Peter MacCallum Cancer Centre
Andrew Grigg
Andrew Grigg Austin Hospital
Kenneth F. Bradstock
Kenneth F. Bradstock Westmead Hospital
Mahmoud Aljurf
Mahmoud Aljurf King Faisal Specialist Hospital & Research Centre
John F. Seymour
John F. Seymour Peter MacCallum Cancer Centre
Andrew W. Roberts
Andrew W. Roberts Walter and Eliza Hall Institute of Medical Research
Monica A. Slavin
Monica A. Slavin Peter MacCallum Cancer Centre
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Hubert Schrezenmeier
Hubert Schrezenmeier University of Ulm
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine but looking for a more flexible or alternative career path, many accredited online degrees offer expanded opportunities in healthcare. For those who prefer administrative roles, exploring the medical billing and coding schools online can provide a streamlined route into healthcare systems with the potential for remote work and career growth.

Nursing also remains a highly in-demand field. If you want to advance without traditional entrance exams, consider lpn to rn programs without teas test requirements to continue your educational journey. For those aspiring to move into leadership, the best online healthcare administration degree programs prepare graduates for management and executive positions within hospitals and clinics.

Registered nurses aiming for advanced practice should explore rn to fnp bridge programs, which enable a focused transition to becoming a Family Nurse Practitioner. These online pathways provide flexible options to earn qualifications while balancing work and family life.

Best Scientists Citing Jeff Szer

Trending Scientists

Recently Published Articles